CIAURRO, VALERIO
 Distribuzione geografica
Continente #
AS - Asia 87
NA - Nord America 63
EU - Europa 52
SA - Sud America 9
AF - Africa 2
OC - Oceania 1
Totale 214
Nazione #
US - Stati Uniti d'America 58
SG - Singapore 44
IT - Italia 20
HK - Hong Kong 13
RU - Federazione Russa 9
CN - Cina 8
VN - Vietnam 8
BR - Brasile 7
IE - Irlanda 5
KR - Corea 5
GB - Regno Unito 4
AT - Austria 3
CA - Canada 3
DE - Germania 3
FI - Finlandia 3
FR - Francia 2
LT - Lituania 2
SA - Arabia Saudita 2
AR - Argentina 1
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
ES - Italia 1
ET - Etiopia 1
HN - Honduras 1
ID - Indonesia 1
IQ - Iraq 1
KE - Kenya 1
MX - Messico 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
QA - Qatar 1
Totale 214
Città #
Singapore 35
San Jose 15
Hong Kong 13
Perugia 12
Ashburn 9
Dublin 5
Moscow 5
Seoul 5
Council Bluffs 4
Santa Clara 4
Boardman 3
Ho Chi Minh City 3
Los Angeles 3
Rome 3
Turku 3
Vienna 3
Arezzo 2
Hanoi 2
Lauterbourg 2
Munich 2
Orem 2
Piscataway 2
Toronto 2
Addis Ababa 1
Baku 1
Barnet 1
Beijing 1
Buffalo 1
Bắc Ninh 1
Dammam 1
Denver 1
Doha 1
Estrela dOeste 1
Governador Valadares 1
Gujranwala 1
Itabaiana 1
Jeddah 1
Jinan 1
London 1
Manchester 1
Medan 1
Mexico City 1
Montreal 1
Muscat 1
Nairobi 1
New York 1
Nuremberg 1
Phoenix 1
Pontes e Lacerda 1
Posadas 1
San Isidro 1
San Pedro Sula 1
Shenyang 1
Sydney 1
Toledo 1
Ubá 1
Videira 1
Vilnius 1
Virginia Beach 1
Điện Bàn 1
Totale 176
Nome #
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML 101
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs) 81
ISOCITRATE DEHYDROGENASES AML-ASSOCIATED POINT MUTATIONS DRIVE A BLOCK OF DIFFERENTIATION IN HUMAN NORMAL CD34+HEMATOPOIETIC CELLS THAT IS RELEASED BY SPECIFIC INHIBITORS 20
Tuned IL3-Zetakine Coupled to a CD33 Costimulatory Receptor As a Dual CAR for Safer and Selective Targeting of Acute Myeloid Leukemia 14
CD123 and CD33 Co-Targeting By Balanced Signaling on CAR-CIK Cells Reduces Potential Off-Target Toxicity While Preserving the Anti-Leukemic Activity of Acute Myeloid Leukemia 9
Totale 225
Categoria #
all - tutte 809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 809


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20239 0 0 0 0 0 0 3 0 4 0 1 1
2023/202417 2 2 0 1 0 0 4 0 2 1 1 4
2024/202553 1 2 0 2 15 4 7 5 7 0 6 4
2025/2026146 7 11 4 14 13 11 18 12 38 18 0 0
Totale 225